Japan Inventory Value by Application and Therapeutic Category: Yearly

Inventory Value: Month End: Require guidance or OTC Drug: Agent for Dental and Oral Use

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Agent for Dental and Oral Use data was reported at 2,370,451.000 JPY th in 2022. This records an increase from the previous number of 2,331,469.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Agent for Dental and Oral Use data is updated yearly, averaging 2,350,960.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 2,373,415.000 JPY th in 2020 and a record low of 2,009,441.000 JPY th in 2019. Inventory Value: Month End: Require guidance or OTC Drug: Agent for Dental and Oral Use data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
2,370,451.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Agent for Dental and Oral Use from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Agent for Dental and Oral Use

Inventory Value: Month End: Require guidance or OTC Drug: Allergy Drug

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Allergy Drug data was reported at 4,978,955.000 JPY th in 2022. This records a decrease from the previous number of 5,194,539.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Allergy Drug data is updated yearly, averaging 5,466,806.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 6,773,188.000 JPY th in 2019 and a record low of 4,978,955.000 JPY th in 2022. Inventory Value: Month End: Require guidance or OTC Drug: Allergy Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
4,978,955.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Allergy Drug from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Allergy Drug

Inventory Value: Month End: Require guidance or OTC Drug: Cardiovascular Preparation

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Cardiovascular Preparation data was reported at 354,350.000 JPY th in 2022. This records a decrease from the previous number of 578,364.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Cardiovascular Preparation data is updated yearly, averaging 567,409.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 578,364.000 JPY th in 2021 and a record low of 354,350.000 JPY th in 2022. Inventory Value: Month End: Require guidance or OTC Drug: Cardiovascular Preparation data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
354,350.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Cardiovascular Preparation from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Cardiovascular Preparation

Inventory Value: Month End: Require guidance or OTC Drug: Cell Activation Drug

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Cell Activation Drug data was reported at 218,628.000 JPY th in 2022. This records a decrease from the previous number of 278,899.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Cell Activation Drug data is updated yearly, averaging 218,376.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 278,899.000 JPY th in 2021 and a record low of 197,895.000 JPY th in 2019. Inventory Value: Month End: Require guidance or OTC Drug: Cell Activation Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
218,628.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Cell Activation Drug from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Cell Activation Drug

Inventory Value: Month End: Require guidance or OTC Drug: Central Nervous System Agent

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Central Nervous System Agent data was reported at 23,519,789.000 JPY th in 2022. This records a decrease from the previous number of 44,888,389.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Central Nervous System Agent data is updated yearly, averaging 40,117,322.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 54,343,315.000 JPY th in 2020 and a record low of 23,519,789.000 JPY th in 2022. Inventory Value: Month End: Require guidance or OTC Drug: Central Nervous System Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
23,519,789.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Central Nervous System Agent from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Central Nervous System Agent

Inventory Value: Month End: Require guidance or OTC Drug: Chemotherapeutics

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Chemotherapeutics data was reported at 130,205.000 JPY th in 2022. This records a decrease from the previous number of 227,307.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Chemotherapeutics data is updated yearly, averaging 238,887.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 260,086.000 JPY th in 2020 and a record low of 130,205.000 JPY th in 2022. Inventory Value: Month End: Require guidance or OTC Drug: Chemotherapeutics data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
130,205.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Chemotherapeutics from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Chemotherapeutics

Inventory Value: Month End: Require guidance or OTC Drug: Crude Drug

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Crude Drug data was reported at 928,308.000 JPY th in 2022. This records an increase from the previous number of 832,559.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Crude Drug data is updated yearly, averaging 876,985.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 928,308.000 JPY th in 2022 and a record low of 806,061.000 JPY th in 2020. Inventory Value: Month End: Require guidance or OTC Drug: Crude Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
928,308.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Crude Drug from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Crude Drug

Inventory Value: Month End: Require guidance or OTC Drug: Dermatological Drug

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Dermatological Drug data was reported at 33,370,402.000 JPY th in 2022. This records a decrease from the previous number of 37,084,508.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Dermatological Drug data is updated yearly, averaging 31,418,355.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 37,084,508.000 JPY th in 2021 and a record low of 28,392,217.000 JPY th in 2020. Inventory Value: Month End: Require guidance or OTC Drug: Dermatological Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
33,370,402.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Dermatological Drug from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Dermatological Drug

Inventory Value: Month End: Require guidance or OTC Drug: Digestive Organ Agent

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Digestive Organ Agent data was reported at 10,804,049.000 JPY th in 2022. This records a decrease from the previous number of 13,456,061.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Digestive Organ Agent data is updated yearly, averaging 14,350,852.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 17,512,584.000 JPY th in 2020 and a record low of 10,804,049.000 JPY th in 2022. Inventory Value: Month End: Require guidance or OTC Drug: Digestive Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
10,804,049.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Digestive Organ Agent from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Digestive Organ Agent

Inventory Value: Month End: Require guidance or OTC Drug: Dispensing Drug

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Dispensing Drug data was reported at 276,299.000 JPY th in 2022. This records an increase from the previous number of 170,223.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Dispensing Drug data is updated yearly, averaging 223,261.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 402,017.000 JPY th in 2020 and a record low of 111,981.000 JPY th in 2019. Inventory Value: Month End: Require guidance or OTC Drug: Dispensing Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
276,299.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Dispensing Drug from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Dispensing Drug

Inventory Value: Month End: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data was reported at 1,196,025.000 JPY th in 2022. This records an increase from the previous number of 1,112,941.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data is updated yearly, averaging 1,162,036.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 1,427,884.000 JPY th in 2019 and a record low of 1,112,941.000 JPY th in 2021. Inventory Value: Month End: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
1,196,025.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription

Inventory Value: Month End: Require guidance or OTC Drug: Drug for In Vitro Diagnostic

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data was reported at 2,881,273.000 JPY th in 2022. This records an increase from the previous number of 571,550.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data is updated yearly, averaging 537,196.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 2,881,273.000 JPY th in 2022 and a record low of 473,617.000 JPY th in 2020. Inventory Value: Month End: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
2,881,273.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Drug for In Vitro Diagnostic from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Drug for In Vitro Diagnostic

Inventory Value: Month End: Require guidance or OTC Drug: Hormones, include Antihormones

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Hormones, include Antihormones data was reported at 14,160.000 JPY th in 2022. This records an increase from the previous number of 4,259.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Hormones, include Antihormones data is updated yearly, averaging 4,297.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 14,160.000 JPY th in 2022 and a record low of 3,687.000 JPY th in 2020. Inventory Value: Month End: Require guidance or OTC Drug: Hormones, include Antihormones data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
14,160.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Hormones, include Antihormones from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Hormones, include Antihormones

Inventory Value: Month End: Require guidance or OTC Drug: Nourishing Tonic

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Nourishing Tonic data was reported at 6,108,488.000 JPY th in 2022. This records a decrease from the previous number of 6,185,447.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Nourishing Tonic data is updated yearly, averaging 6,606,132.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 8,044,141.000 JPY th in 2020 and a record low of 6,108,488.000 JPY th in 2022. Inventory Value: Month End: Require guidance or OTC Drug: Nourishing Tonic data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
6,108,488.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Nourishing Tonic from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Nourishing Tonic

Inventory Value: Month End: Require guidance or OTC Drug: Other Metabolic Drug

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Other Metabolic Drug data was reported at 3,800,206.000 JPY th in 2022. This records a decrease from the previous number of 4,174,135.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Other Metabolic Drug data is updated yearly, averaging 4,465,825.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 4,904,379.000 JPY th in 2020 and a record low of 3,800,206.000 JPY th in 2022. Inventory Value: Month End: Require guidance or OTC Drug: Other Metabolic Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
3,800,206.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Other Metabolic Drug from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Other Metabolic Drug

Inventory Value: Month End: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data was reported at 235,072.000 JPY th in 2022. This records a decrease from the previous number of 270,598.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data is updated yearly, averaging 271,263.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 361,023.000 JPY th in 2019 and a record low of 235,072.000 JPY th in 2022. Inventory Value: Month End: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
235,072.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose

Inventory Value: Month End: Require guidance or OTC Drug: Parasitic Veterinary Drug

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Parasitic Veterinary Drug data was reported at 10,819.000 JPY th in 2022. This records an increase from the previous number of 6,114.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Parasitic Veterinary Drug data is updated yearly, averaging 12,961.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 23,014.000 JPY th in 2020 and a record low of 6,114.000 JPY th in 2021. Inventory Value: Month End: Require guidance or OTC Drug: Parasitic Veterinary Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
10,819.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Parasitic Veterinary Drug from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Parasitic Veterinary Drug

Inventory Value: Month End: Require guidance or OTC Drug: Peripheral Nervous System Agent

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Peripheral Nervous System Agent data was reported at 118,581.000 JPY th in 2022. This records an increase from the previous number of 43,339.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Peripheral Nervous System Agent data is updated yearly, averaging 106,387.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 163,357.000 JPY th in 2020 and a record low of 43,339.000 JPY th in 2021. Inventory Value: Month End: Require guidance or OTC Drug: Peripheral Nervous System Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
118,581.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Peripheral Nervous System Agent from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Peripheral Nervous System Agent

Inventory Value: Month End: Require guidance or OTC Drug: Public Health Drug

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Public Health Drug data was reported at 4,277,529.000 JPY th in 2022. This records a decrease from the previous number of 5,556,200.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Public Health Drug data is updated yearly, averaging 4,916,864.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 6,011,411.000 JPY th in 2019 and a record low of 4,244,313.000 JPY th in 2020. Inventory Value: Month End: Require guidance or OTC Drug: Public Health Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
4,277,529.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Public Health Drug from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Public Health Drug

Inventory Value: Month End: Require guidance or OTC Drug: Respiratory Organ Agent

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Respiratory Organ Agent data was reported at 2,120,775.000 JPY th in 2022. This records a decrease from the previous number of 3,490,265.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Respiratory Organ Agent data is updated yearly, averaging 3,235,211.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 3,796,307.000 JPY th in 2020 and a record low of 2,120,775.000 JPY th in 2022. Inventory Value: Month End: Require guidance or OTC Drug: Respiratory Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
2,120,775.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Respiratory Organ Agent from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Respiratory Organ Agent

Inventory Value: Month End: Require guidance or OTC Drug: Sensory Organ Agent

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Sensory Organ Agent data was reported at 18,481,617.000 JPY th in 2022. This records an increase from the previous number of 16,700,778.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Sensory Organ Agent data is updated yearly, averaging 17,894,011.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 22,657,146.000 JPY th in 2020 and a record low of 16,700,778.000 JPY th in 2021. Inventory Value: Month End: Require guidance or OTC Drug: Sensory Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
18,481,617.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Sensory Organ Agent from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Sensory Organ Agent

Inventory Value: Month End: Require guidance or OTC Drug: Traditional Chinese Medicines

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Traditional Chinese Medicines data was reported at 5,614,918.000 JPY th in 2022. This records an increase from the previous number of 5,222,562.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Traditional Chinese Medicines data is updated yearly, averaging 5,418,740.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 6,102,329.000 JPY th in 2020 and a record low of 4,646,634.000 JPY th in 2019. Inventory Value: Month End: Require guidance or OTC Drug: Traditional Chinese Medicines data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
5,614,918.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Traditional Chinese Medicines from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Traditional Chinese Medicines

Inventory Value: Month End: Require guidance or OTC Drug: Urogenital Organ and Anus Drug

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data was reported at 2,573,225.000 JPY th in 2022. This records an increase from the previous number of 2,345,379.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data is updated yearly, averaging 2,337,336.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 2,573,225.000 JPY th in 2022 and a record low of 2,260,272.000 JPY th in 2019. Inventory Value: Month End: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
2,573,225.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Urogenital Organ and Anus Drug from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Urogenital Organ and Anus Drug

Inventory Value: Month End: Require guidance or OTC Drug: Vitamins

2019 - 2022 | Yearly | JPY th | Ministry of Health, Labour and Welfare

Inventory Value: Month End: Require guidance or OTC Drug: Vitamins data was reported at 10,609,681.000 JPY th in 2022. This records a decrease from the previous number of 17,195,590.000 JPY th for 2021. Inventory Value: Month End: Require guidance or OTC Drug: Vitamins data is updated yearly, averaging 16,883,470.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 18,072,957.000 JPY th in 2019 and a record low of 10,609,681.000 JPY th in 2022. Inventory Value: Month End: Require guidance or OTC Drug: Vitamins data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT035: Inventory Value by Application and Therapeutic Category: Yearly.

Last Frequency Range
10,609,681.000 2022 yearly 2019 - 2022

View Japan's Inventory Value: Month End: Require guidance or OTC Drug: Vitamins from 2019 to 2022 in the chart:

Japan Inventory Value: Month End: Require guidance or OTC Drug: Vitamins
Inventory Value: Month End: Require guidance or OTC Drug: Agent for Dental and Oral Use
Inventory Value: Month End: Require guidance or OTC Drug: Allergy Drug
Inventory Value: Month End: Require guidance or OTC Drug: Cardiovascular Preparation
Inventory Value: Month End: Require guidance or OTC Drug: Cell Activation Drug
Inventory Value: Month End: Require guidance or OTC Drug: Central Nervous System Agent
Inventory Value: Month End: Require guidance or OTC Drug: Chemotherapeutics
Inventory Value: Month End: Require guidance or OTC Drug: Crude Drug
Inventory Value: Month End: Require guidance or OTC Drug: Dermatological Drug
Inventory Value: Month End: Require guidance or OTC Drug: Digestive Organ Agent
Inventory Value: Month End: Require guidance or OTC Drug: Dispensing Drug
Inventory Value: Month End: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription
Inventory Value: Month End: Require guidance or OTC Drug: Drug for In Vitro Diagnostic
Inventory Value: Month End: Require guidance or OTC Drug: Hormones, include Antihormones
Inventory Value: Month End: Require guidance or OTC Drug: Nourishing Tonic
Inventory Value: Month End: Require guidance or OTC Drug: Other Metabolic Drug
Inventory Value: Month End: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose
Inventory Value: Month End: Require guidance or OTC Drug: Parasitic Veterinary Drug
Inventory Value: Month End: Require guidance or OTC Drug: Peripheral Nervous System Agent
Inventory Value: Month End: Require guidance or OTC Drug: Public Health Drug
Inventory Value: Month End: Require guidance or OTC Drug: Respiratory Organ Agent
Inventory Value: Month End: Require guidance or OTC Drug: Sensory Organ Agent
Inventory Value: Month End: Require guidance or OTC Drug: Traditional Chinese Medicines
Inventory Value: Month End: Require guidance or OTC Drug: Urogenital Organ and Anus Drug
Inventory Value: Month End: Require guidance or OTC Drug: Vitamins
Unlimited access tailored to your data needs
Flexible monthly access to CEIC data